Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 19.26%151.27M | -2.75%42.22M | -20.47%24.1M | 17.88%36.81M | 119.85%48.14M | 4,076.56%126.84M | 1,329.67%43.42M | 30.3M | 31.22M | 21.9M |
Operating revenue | 19.26%151.27M | -2.75%42.22M | -20.47%24.1M | 17.88%36.81M | 119.85%48.14M | 4,076.56%126.84M | 1,329.67%43.42M | --30.3M | --31.22M | --21.9M |
Cost of revenue | 14.35%123.16M | 20.41%34.94M | -0.92%29.8M | 7.11%30.57M | 38.74%27.86M | 14,299.47%107.71M | 3,779.01%29.02M | 30.08M | 28.54M | 20.08M |
Gross profit | 46.91%28.11M | -49.42%7.29M | -2,632.89%-5.7M | 132.22%6.24M | 1,016.18%20.28M | 735.91%19.13M | 529.27%14.4M | 225K | 2.69M | 1.82M |
Operating expense | 69.41%126.37M | 83.24%40.6M | 78.51%36.11M | 57.83%27.51M | 49.85%22.15M | -0.22%74.59M | -3.17%22.16M | 13.86%20.23M | 4.28%17.43M | -15.04%14.78M |
Selling and administrative expenses | 17.48%32.66M | 36.28%9.29M | 30.64%8.92M | -3.48%8.37M | 10.83%6.08M | -60.76%27.8M | -64.09%6.82M | -61.55%6.83M | -48.11%8.67M | -68.47%5.48M |
-General and administrative expense | 17.48%32.66M | 36.28%9.29M | 30.64%8.92M | -3.48%8.37M | 10.83%6.08M | -60.76%27.8M | -64.09%6.82M | -61.55%6.83M | -48.11%8.67M | -68.47%5.48M |
Depreciation amortization depletion | 73.37%102.45M | 116.06%36.32M | 76.58%28.64M | 40.51%20.25M | 47.95%17.24M | 1,249.77%59.09M | 286.24%16.81M | 147,327.27%16.22M | 180,050.00%14.41M | 166,400.00%11.66M |
-Depreciation and amortization | 73.37%102.45M | 116.06%36.32M | 76.58%28.64M | 40.51%20.25M | 47.95%17.24M | 1,249.77%59.09M | 286.24%16.81M | 147,327.27%16.22M | 180,050.00%14.41M | 166,400.00%11.66M |
Other operating expenses | 28.94%-8.74M | -240.49%-5.01M | 48.70%-1.44M | 80.38%-1.11M | 50.25%-1.17M | -2,584.72%-12.3M | ---1.47M | ---2.82M | ---5.65M | ---2.36M |
Operating profit | -77.17%-98.26M | -329.73%-33.31M | -109.01%-41.81M | -44.27%-21.27M | 85.60%-1.87M | 23.47%-55.46M | 62.35%-7.75M | -12.60%-20M | 11.80%-14.74M | 25.49%-12.96M |
Net non-operating interest income expense | 191.34%1.68M | 46.31%-233K | 236.69%842K | 248.04%681K | 218.77%386K | -2,452.56%-1.84M | -1,450.00%-434K | -1,220.00%-616K | -1,145.45%-460K | -4,742.86%-325K |
Non-operating interest income | 1,963.41%3.38M | 586.54%357K | 10,700.00%1.19M | 4,112.00%1.05M | 934.21%786K | -23.72%164K | -52.29%52K | -80.00%11K | -43.18%25K | 985.71%76K |
Non-operating interest expense | -14.56%1.71M | 21.40%590K | -44.82%346K | -23.30%372K | -0.25%400K | 1,359.12%2M | 254.74%486K | --627K | --485K | --401K |
Other net income (expense) | 48.96%52.26M | 115.66%49.08M | -5,597.56%-49.59M | 122.43%5.82M | 433.16%46.95M | -0.26%35.08M | 178.03%22.76M | -98.83%902K | 120.85%2.62M | 8,177.98%8.81M |
Gain on sale of security | 46.66%55.19M | 145.31%51.79M | -1,835.41%-50.43M | 39.68%5.67M | 404.08%48.17M | -48.88%37.63M | 150.92%21.11M | -96.24%2.91M | 6,344.44%4.06M | 19,806.25%9.56M |
Earnings from equity interest | 84.82%-384K | -184.41%-1.39M | 142.39%847K | 59.68%-577K | 198.40%738K | 93.16%-2.53M | --1.65M | ---2M | 88.15%-1.43M | -390.20%-750K |
Other non- operating income (expenses) | -14,864.71%-2.54M | -131,000.00%-1.31M | 33.33%-4K | 6,158.33%727K | ---1.96M | ---17K | --1K | ---6K | ---12K | ---- |
Income before tax | -99.54%-44.32M | 6.61%15.54M | -359.26%-90.56M | -17.32%-14.76M | 1,114.14%45.46M | 40.32%-22.21M | 129.27%14.57M | -133.26%-19.72M | 56.94%-12.58M | 74.38%-4.48M |
Income tax | -91.08%318K | -149.56%-1.97M | -246.58%-3.8M | -14.15%528K | 7,848.57%5.56M | 93.86%3.57M | 116.25%3.98M | -1.1M | 615K | 70K |
Net income | -73.16%-44.64M | 65.27%17.51M | -365.89%-86.75M | -15.86%-15.29M | 976.35%39.9M | 33.99%-25.78M | 120.52%10.6M | -131.41%-18.62M | 54.83%-13.2M | 73.98%-4.55M |
Net income continuous Operations | -73.16%-44.64M | 65.27%17.51M | -365.89%-86.75M | -15.86%-15.29M | 976.35%39.9M | 33.99%-25.78M | 120.52%10.6M | -131.41%-18.62M | 54.83%-13.2M | 73.98%-4.55M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -73.16%-44.64M | 65.27%17.51M | -365.89%-86.75M | -15.86%-15.29M | 976.35%39.9M | 33.99%-25.78M | 120.52%10.6M | -131.41%-18.62M | 54.83%-13.2M | 73.98%-4.55M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -73.16%-44.64M | 65.27%17.51M | -365.89%-86.75M | -15.86%-15.29M | 976.35%39.9M | 33.99%-25.78M | 120.52%10.6M | -131.41%-18.62M | 54.83%-13.2M | 73.98%-4.55M |
Basic earnings per share | -40.00%-0.14 | 20.00%0.06 | -271.43%-0.26 | 0.00%-0.05 | 750.00%0.13 | 37.50%-0.1 | 123.81%0.05 | -129.17%-0.07 | 58.33%-0.05 | 71.43%-0.02 |
Diluted earnings per share | -40.00%-0.14 | 20.00%0.06 | -271.43%-0.26 | 5.62%-0.05 | 750.00%0.13 | 37.50%-0.1 | 123.81%0.05 | -129.17%-0.07 | 55.85%-0.053 | 71.43%-0.02 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |